Clinical Trial Update: CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial at University of California, Davis evaluated ImmunoLin supplements for HIV enteropathy; the study is completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ImmunoLin

Snippet

Sponsor: University of California, Davis | Conditions: HIV | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2017-03-03